Developing a Diverse Next Generation of Leaders in Respiratory Science
Developing a Diverse Next Generation of Leaders in Respiratory Science
批准号:
10555145
负责人:
Laura Elise Crotty Alexander
金额:
$38.31万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
This proposal is for a new training program that capitalizes on our major local strengths in respiratory physiology
and pulmonary disease. Over time, the field of physiology and pathophysiology has evolved to solve new
problems identified from clinical management of lung airway, interstitial and vascular diseases and to extend the
new discoveries from genetic, genomic, cell and molecular studies to define pathogenic mechanisms and
develop novel therapeutic interventions for lung diseases. We remain focused on the importance of integrated
function and systems biology and thus we use the concepts of physiology as an integrator across respiratory
science studied at multiple levels. With the success of our recent T32 and recruitment efforts, our respiratory
science has broadened to include strength in genetics, (epi)genomics, molecular and cellular biology. While we
view our science as cutting edge, we pride ourselves on the fact that our trainees do not just focus on a single
molecule or gene but rather keep in mind the importance of integrated function and translational research. Our
MPIs include diverse strengths in Pulmonary, Sleep, Genomics, Critical Care, Physiology and Respiratory
Science. The MPIs have mutual respect, complementary expertise, shared vision for scientific progress and a
strong commitment to developing a superb next generation of leaders with rich diversity. To improve the quality
of mentoring, we also removed less effective mentors while adding more R01-funded preceptors and formalizing
the levels of faculty participation based on success in research training, research productivity and current
research funding. We have made both Sleep and Pediatrics as major scientific foci, addressing major national
shortages in these areas. We utilize individual development plans, overseen by the MPIs, Preceptors and senior
advisors, for all of our trainees to empower people with diverse backgrounds. We promote collaboration between
MDs and PhDs, ensure that everyone has experience and competency in inter-, trans- and multi-disciplinary
research, and ensure all of our trainees have a strong foundation in physiological approaches that provides a
clinical context for research problems studied at any level. We promote cohesiveness, team spirit and a unique
identity for our trainees via common activities involving all of our trainees and mentors/preceptors such as
frequent scholarly meetings, career development sessions and quarterly retreats. We are committed to a training
program that includes every phase of academic career development, from ‘cradle to grave’ including developing
junior faculty into independent investigators, and even improving the mentoring skills in our senior faculty. We
also remain committed to diversifying the next generation of respiratory scientists as demonstrated by our long-
term track record and recent recruitments. The lack of a robust pipeline for multidisciplinary researchers who can
apply modern integrative approaches to problems in respiratory science is a crisis which has been further
amplified by the COVID pandemic, but it is a challenge that we are well-qualified and eager to address.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1177/00368504231207209
发表时间:
2023-10
期刊:
SCIENCE PROGRESS
影响因子:
2.1
作者:
[Pearce, Alex K., Zawaydeh, Qais, Mcguire, W. Cameron, Husain, Abdurrahman, Ayoub, Claudia, Sweeney, Daniel A., Cotton, Shannon A., Malhotra, Atul]
通讯作者:
Malhotra, Atul
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial.
替泽帕肽治疗阻塞性睡眠呼吸暂停:SURMOUNT -OSA 3 期试验的基本原理、设计和样本基线特征。
DOI:
10.1016/j.cct.2024.107516
发表时间:
2024
期刊:
Contemporary clinical trials
影响因子:
2.2
作者:
[Malhotra,Atul, Bednarik,Josef, Chakladar,Sujatro, Dunn,JuliaP, Weaver,Terri, Grunstein,Ron, Fietze,Ingo, Redline,Susan, Azarbarzin,Ali, Sands,ScottA, Schwab,RichardJ, Bunck,MathijsC]
通讯作者:
Bunck,MathijsC
Convergence of Vitamin E, THC, Nicotine, Propylene Glycol and Glycerin Effects on Lung Inflammation When Vaped
-
批准号:10371746
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2022
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Convergence of Vitamin E, THC, Nicotine, Propylene Glycol and Glycerin Effects on Lung Inflammation When Vaped
-
批准号:10546469
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2022
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Electronic Cigarette Vapor Inhalation Adversely Affects Lung Cellular and Physiologic Function and Alters Systemic Inflammatory Pathways
-
批准号:10220439
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2020
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Hypoxia inducible factors in pulmonary endothelial cells regulate allergic inflammatory airways disease
-
批准号:10292906
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Hypoxia inducible factors in pulmonary endothelial cells regulate allergic inflammatory airways disease
-
批准号:10515302
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Hypoxia inducible factors in pulmonary endothelial cells regulate allergic inflammatory airways disease
-
批准号:10045518
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Genetic and Pharmacologic Evaluation of the Role of HIF-1a in asthma
-
批准号:8305975
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Genetic and Pharmacologic Evaluation of the Role of HIF-1a in asthma
-
批准号:8698286
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Genetic and Pharmacologic Evaluation of the Role of HIF-1a in asthma
-
批准号:8143209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Genetic and Pharmacologic Evaluation of the Role of HIF-1a in asthma
-
批准号:8402123
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
Genetic and Pharmacologic Evaluation of the Role of HIF-1a in asthma
-
批准号:8795680
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Laura Elise Crotty Alexander
-
依托单位:
国内基金
海外基金
Next Generation Majorana Nanowire Hybrids
-
批准号:--
-
项目类别:--
-
资助金额:20万元
-
批准年份:2020
-
负责人:Panagiotis Kotetes
-
依托单位: